---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-007120"
form_type: "8-K"
ticker: "BLGO"
cik: "0000880242"
company_name: "BIOLARGO, INC."
filed_at: "2023-03-20T23:59:59+00:00"
generated_at: "2026-06-17T23:22:38.602134+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioLargo expects Q1 2023 revenue >4x YoY, seventh consecutive quarterly growth record

## Summary
- Q1 2023 preliminary revenues expected to surpass Q4 2022 record; QoQ growth >50%.
- Revenue driven by Pooph pet-odor product from Ikigai Marketing Works.
- Company not yet profitable but net losses trending down as revenue increases.
- 2022 preliminary YoY revenue growth at least 125%; eighth consecutive annual growth.
- Company expects to file 2022 annual report by end of March; earnings call April 3.

## SEC filing metadata
- accession: 0001437749-23-007120
- form_type: 8-K
- ticker: BLGO
- cik: 0000880242
- company_name: BIOLARGO, INC.
- filed_at: 2023-03-20T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/880242/000143774923007120/0001437749-23-007120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/880242/000143774923007120/blgo20230317_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-007120
- JSON: https://secwatch.observer/filing/0001437749-23-007120.json
- Plain text: https://secwatch.observer/filing/0001437749-23-007120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.